[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10441-10442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03584]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control, (BSC, NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control, (BSC, NCIPC). This 
meeting is open to the public limited only by the space and ports 
available. There will be 2,000 telephone ports available. There will be 
a public comment period at the end of the meeting; from 3:00 p.m.-3:45 
p.m., EDT.

DATES: The meeting will be held on April 30, 2020, 12:30 p.m. to 3:50 
p.m., EDT.

ADDRESSES: Teleconference: Dial-In Number: 1-800-369-3110, Participant 
Code: 7563795.

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770) 
488-1430; Email address: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury. The Board of Scientific 
Counselors makes recommendations regarding policies, strategies, 
objectives, and priorities; and reviews progress toward injury 
prevention goals and provides evidence in injury prevention-related 
research and programs. The Board also provides advice on the 
appropriate balance of intramural and extramural research, the 
structure, progress and performance of intramural programs. The Board 
is designed to provide guidance on extramural scientific program 
matters, including the: (1) Review of extramural research concepts for 
funding opportunity announcements; (2) conduct of Secondary Peer Review 
of extramural research grants, cooperative agreements, and contracts 
applications received in response to the funding opportunity 
announcements as it relates to the Center's programmatic balance and 
mission; (3) submission of secondary review recommendations to the 
Center Director of applications to be considered for funding support; 
(4) review of research portfolios; and (5) review of program proposals.
    Matters To Be Considered: The agenda will discuss an update on the 
CDC Opioid Prescribing Estimates Project, the Management of Acute and 
Chronic Pain: Opportunities for Stakeholder Engagement, and Public 
Comments. In addition, an update will be provided on the formation of 
the BSC, NCIPC Opioid Workgroup. Agenda items are subject to change as 
priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to

[[Page 10442]]

announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-03584 Filed 2-21-20; 8:45 am]
BILLING CODE 4163-18-P